| 1 |
34535390 | Radix Tetrastigma Extracts Enhance the Chemosensitivity in Triple-Negative Breast Cancer Via Inhibiting PI3K/Akt/mTOR-Mediated Autophagy. | 2022 Feb |
5 |
| 2 |
33300063 | WWOX promotes apoptosis and inhibits autophagy in paclitaxel‑treated ovarian carcinoma cells. | 2021 Feb |
3 |
| 3 |
33594306 | Formononetin ameliorates the drug resistance of Taxol resistant triple negative breast cancer by inhibiting autophagy. | 2021 |
5 |
| 4 |
33758505 | Synergistic Inhibition of Drug-Resistant Colon Cancer Growth with PI3K/mTOR Dual Inhibitor BEZ235 and Nano-Emulsioned Paclitaxel via Reducing Multidrug Resistance and Promoting Apoptosis. | 2021 |
1 |
| 5 |
33764366 | CCL26 is upregulated by nab-paclitaxel in pancreatic cancer-associated fibroblasts and promotes PDAC invasiveness through activation of the PI3K/AKT/mTOR pathway. | 2021 Apr 15 |
1 |
| 6 |
33788730 | Effect of Metformin in Combination With Trametinib and Paclitaxel on Cell Survival and Metastasis in Melanoma Cells. | 2021 Mar |
1 |
| 7 |
33809079 | GBP5 Serves as a Potential Marker to Predict a Favorable Response in Triple-Negative Breast Cancer Patients Receiving a Taxane-Based Chemotherapy. | 2021 Mar 12 |
1 |
| 8 |
34229754 | Apatinib induces endoplasmic reticulum stress-mediated apoptosis and autophagy and potentiates cell sensitivity to paclitaxel via the IRE-1α-AKT-mTOR pathway in esophageal squamous cell carcinoma. | 2021 Jul 6 |
3 |
| 9 |
34393439 | Molecular docking of potential inhibitors with the mTOR protein. | 2021 |
2 |
| 10 |
34479917 | Paclitaxel Impedes EGFR-mutated PC9 Cell Growth via Reactive Oxygen Species-mediated DNA Damage and EGFR/PI3K/AKT/mTOR Signaling Pathway Suppression. | 2021 Sep-Oct |
2 |
| 11 |
34512368 | Targeting Autophagy with Natural Compounds in Cancer: A Renewed Perspective from Molecular Mechanisms to Targeted Therapy. | 2021 |
1 |
| 12 |
34584572 | Targeting Mps1 in combination with paclitaxel inhibits osteosarcoma progression by modulating spindle assembly checkpoint and Akt/mTOR signaling. | 2021 Nov |
3 |
| 13 |
33165766 | Paclitaxel-Loaded Colloidal Silica and TPGS-Based Solid Self-Emulsifying System Interferes Akt/mTOR Pathway in MDA-MB-231 and Demonstrates Anti-tumor Effect in Syngeneic Mammary Tumors. | 2020 Nov 9 |
1 |
| 14 |
33292283 | Resveratrol, curcumin, paclitaxel and miRNAs mediated regulation of PI3K/Akt/mTOR pathway: go four better to treat bladder cancer. | 2020 Nov 23 |
1 |
| 15 |
30325723 | Rapamycin alleviates proinflammatory cytokines and nociceptive behavior induced by chemotherapeutic paclitaxel. | 2019 Jan |
3 |
| 16 |
30782035 | NEAT1 mediates paclitaxel-resistance of non-small cell of lung cancer through activation of Akt/mTOR signalling pathway. | 2019 Dec |
1 |
| 17 |
31467112 | Breast Cancer Risk-Associated SNPs in the mTOR Promoter Form De Novo KLF5- and ZEB1-Binding Sites that Influence the Cellular Response to Paclitaxel. | 2019 Nov |
7 |
| 18 |
31934276 | BEZ235 enhances chemosensitivity of paclitaxel in hepatocellular carcinoma through inhibiting the PI3K/Akt/mTOR pathway. | 2019 |
4 |
| 19 |
29369007 | Combination therapy Eve and Pac to induce apoptosis in cervical cancer cells by targeting PI3K/AKT/mTOR pathways. | 2018 Feb |
1 |
| 20 |
29374144 | Dual PI3K/mTOR inhibitor BEZ235 as a promising therapeutic strategy against paclitaxel-resistant gastric cancer via targeting PI3K/Akt/mTOR pathway. | 2018 Jan 26 |
6 |
| 21 |
29416920 | Everolimus following 5-aza-2-deoxycytidine is a promising therapy in paclitaxel-resistant clear cell carcinoma of the ovary. | 2018 |
1 |
| 22 |
29790111 | Potential of the dual mTOR kinase inhibitor AZD2014 to overcome paclitaxel resistance in anaplastic thyroid carcinoma. | 2018 Aug |
1 |
| 23 |
30175145 | Study on Biological Characteristics and Mechanism of Paclitaxel Induced Drug Resistance in Endometrial Carcinoma Cells. | 2018 |
1 |
| 24 |
30254455 | Low-frequency ultrasound enhances chemotherapy sensitivity and induces autophagy in PTX-resistant PC-3 cells via the endoplasmic reticulum stress-mediated PI3K/Akt/mTOR signaling pathway. | 2018 |
4 |
| 25 |
27932243 | Inhibition of mTOR/eIF4E by anti-viral drug ribavirin effectively enhances the effects of paclitaxel in oral tongue squamous cell carcinoma. | 2017 Jan 22 |
2 |
| 26 |
28104295 | Systematic drug sensitivity testing reveals synergistic growth inhibition by dasatinib or mTOR inhibitors with paclitaxel in ovarian granulosa cell tumor cells. | 2017 Mar |
2 |
| 27 |
28137584 | Anthelminthic drug niclosamide sensitizes the responsiveness of cervical cancer cells to paclitaxel via oxidative stress-mediated mTOR inhibition. | 2017 Mar 4 |
1 |
| 28 |
28664915 | Kinase-driven metabolic signalling as a predictor of response to carboplatin-paclitaxel adjuvant treatment in advanced ovarian cancers. | 2017 Aug 8 |
1 |
| 29 |
28849180 | Silencing Aurora A leads to re-sensitization of breast cancer cells to Taxol through downregulation of SRC-mediated ERK and mTOR pathways. | 2017 Oct |
2 |
| 30 |
28961834 | A phase II study of temsirolimus added to low-dose weekly carboplatin and paclitaxel for patients with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC). | 2017 Oct 1 |
1 |
| 31 |
26744318 | MicroRNA 100 sensitizes luminal A breast cancer cells to paclitaxel treatment in part by targeting mTOR. | 2016 Feb 2 |
3 |
| 32 |
26913996 | Enhanced Cytotoxicity to Cancer Cells by Codelivery and Controlled Release of Paclitaxel-loaded Sirolimus-conjugated Albumin Nanoparticles. | 2016 Aug |
2 |
| 33 |
27090655 | Vascular endothelial growth factor A as predictive marker for mTOR inhibition in relapsing high-grade serous ovarian cancer. | 2016 Apr 18 |
3 |
| 34 |
27259248 | Study of single nucleotide polymorphisms of FBW7 and its substrate genes revealed a predictive factor for paclitaxel plus cisplatin chemotherapy in Chinese patients with advanced esophageal squamous cell carcinoma. | 2016 Jul 12 |
1 |
| 35 |
27338042 | MiR-18a upregulation enhances autophagy in triple negative cancer cells via inhibiting mTOR signaling pathway. | 2016 Jun |
1 |
| 36 |
28105210 | Mammalian target of rapamycin inhibitor RAD001 sensitizes endometrial cancer cells to paclitaxel-induced apoptosis via the induction of autophagy. | 2016 Dec |
1 |
| 37 |
25983747 | Molecular mechanism of local drug delivery with Paclitaxel-eluting membranes in biliary and pancreatic cancer: new application for an old drug. | 2015 |
2 |
| 38 |
26068792 | SPAG5 upregulation predicts poor prognosis in cervical cancer patients and alters sensitivity to taxol treatment via the mTOR signaling pathway. | 2015 Jun 11 |
1 |
| 39 |
26497956 | Demethylation of HIN-1 reverses paclitaxel-resistance of ovarian clear cell carcinoma through the AKT-mTOR signaling pathway. | 2015 Oct 24 |
3 |
| 40 |
24569835 | Colocalized delivery of rapamycin and paclitaxel to tumors enhances synergistic targeting of the PI3K/Akt/mTOR pathway. | 2014 Jul |
3 |
| 41 |
24659394 | Combination of Cl‑IB‑MECA with paclitaxel is a highly effective cytotoxic therapy causing mTOR‑dependent autophagy and mitotic catastrophe on human melanoma cells. | 2014 Jun |
1 |
| 42 |
24853425 | SPAG5 upregulation predicts poor prognosis in cervical cancer patients and alters sensitivity to taxol treatment via the mTOR signaling pathway. | 2014 May 22 |
4 |
| 43 |
25153728 | The anti-tumor activator sMEK1 and paclitaxel additively decrease expression of HIF-1α and VEGF via mTORC1-S6K/4E-BP-dependent signaling pathways. | 2014 Aug 15 |
1 |
| 44 |
23681233 | Hypoxia counteracts taxol-induced apoptosis in MDA-MB-231 breast cancer cells: role of autophagy and JNK activation. | 2013 May 16 |
3 |
| 45 |
24060847 | Molecular pathways and functional analysis of miRNA expression associated with paclitaxel-induced apoptosis in hepatocellular carcinoma cells. | 2013 |
1 |
| 46 |
24070631 | Inhibition of glycogen synthase kinase 3β activity with lithium prevents and attenuates paclitaxel-induced neuropathic pain. | 2013 Dec 19 |
1 |
| 47 |
24294361 | Potential biomarkers for paclitaxel sensitivity in hypopharynx cancer cell. | 2013 |
1 |
| 48 |
22252099 | Metformin potentiates the effects of paclitaxel in endometrial cancer cells through inhibition of cell proliferation and modulation of the mTOR pathway. | 2012 May |
3 |
| 49 |
22765290 | Plant natural compounds: targeting pathways of autophagy as anti-cancer therapeutic agents. | 2012 Oct |
1 |
| 50 |
19688827 | Rapamycin potentiates the effects of paclitaxel in endometrial cancer cells through inhibition of cell proliferation and induction of apoptosis. | 2010 Mar 1 |
1 |